Search Results 571-580 of 38012 for Two-phase

  1. Neurology - Clinical trials - Mayo Clinic

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  2. Lyme disease - Symptoms and causes - Mayo Clinic

    Swollen lymph nodes. Stage 2. Without treatment, Lyme disease can get worse. The symptoms often show up within 3 to 10 weeks after a tick bite.

  3. Facial reanimation surgery - Mayo Clinic

    This is often done in two stages. In the first stage, the surgeon borrows some of the nerves on the other side of the face to provide function on the affected ...

  4. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    Approximately 687 subjects will be randomized to one of the following treatment arms in a 2:1 ratio, fruquintinib plus BSC or placebo plus BSC. Regorafenib in ...

  5. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. A Study to Evaluate AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. Hodgkin Clinical Trials - Mayo Clinic Research

    Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma Rochester, MN. This open-label, randomized, 2-arm, multicenter, phase 3 ...

  8. Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, and Acute Myeloid Leukemia - Mayo Clinic

    A Phase 2 study to investigate the antitumor activity in terms of overall response rate (ORR) of tipifarnib in approximately 20 eligible subjects with CMML.

  9. A Phase I study of Epalrestat Therapy in a Single Patient with Phosphomannomutase Deficiency (PMM2-CDG) - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Neurology - Clinical trials

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...